4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-15-007104
CIK 0001316175operating
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 8:02 PM ET
Size
5.3 KB
Accession
0001214659-15-007104
Insider Transaction Report
Form 4
ODINK DEBRA
VP, Pharmaceutical R&D
Transactions
- Sale
Common Stock
2015-10-12$6.15/sh−1,205$7,411→ 7,896 total
Holdings
- 13,855(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2015.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 8:02 PM ET
- Size
- 5.3 KB